Insights Widest with the analysis, Proactive gives perspectives that others don't.

Revive Therapeutics - Revive Therapeutics Revive Therapeutics returns with repurposed gout drug to fight COVID-19 and push into psychedelic medicine

The company is finalizing an FDA application to start Phase 3 clinical trial to evaluate...

6 days, 12 hours ago
Deep dive

Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep...

The company has a growing pipeline of drugs and therapies to treat metastatic cancer bone pain,...

6 days, 12 hours ago

Revive Therapeutics: Initiation report

Revive Therapeutics (CSE:RVV, OTCQB:RVVTF) is a speciality life sciences company focussed on...

1 week, 1 day ago
Deep dive

PreveCeutical turns focus on developing preventive and curative therapies to...

The health sciences company has five research and development programs, including gene therapy,...

1 week, 6 days ago


Nextleaf Solutions announces Supply Partnership

Nextleaf Solutions (CSE: OILS) (OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive Vancouver with news the company has signed a substantial deal with a multi-licensed cannabis producer in British Columbia to purchase 50 kilos of THC distillate. Pedersen says that producer is...

1 day, 9 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.